Overview

Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to determine the extent of bioavailability of two low dose estradiol/norethisterone acetate (NETA) preparations with a marketed estradiol/norethisterone acetate (NETA) preparation.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Hormones
Norethindrone
Norethindrone Acetate
Polyestradiol phosphate